Marc Schneider studied physics at the TU Kaiserlautern, the Ruprecht-Karls-Universität Heidelberg and the FU Berlin. He completed his diploma thesis at the Max Delbrück Center for Molecular Medicine in Berlin-Buch. He completed his doctorate at the Max Planck Institute of Colloids and Interfaces in 2002 at the University of Potsdam in Experimental Physics. After postdoctoral research positions at the Max Planck Institute of Colloids and Interfaces, the University of Genoa, and at the Chair of Biopharmaceutics and Pharmaceutical Technology at Saarland University, he became Junior Professor for Pharmaceutical Nanotechnology (2007). After a research stay at the Chemistry Institute of the Chinese Academy of Sciences in Beijing with Prof. Mingyuan Gao, he took up a professorship for Pharmaceutical Technology and Biopharmacy in Marburg (2013). Since 2015, he was appointed the Chair of Biopharmaceutics and Pharmaceutical Technology at Saarland University.
He authored more than 150 original scientific articles, 17 articles in proceedings, 14 book chapters, 5 editorials and holds 9 patents
Prof. Schneider was co-editor-in-chief of Drug Delivery Letters and is involved in scientific advisory boards of Pharmaceutics and the European Journal of Pharmaceutics and Biopharmaceutics and was, among other things, president of the Controlled Release Society Local Chapter Germany.
His research focuses on the production and application of colloidal drug carrier systems and the characterization
Marc Schneider studied physics at the TU Kaiserlautern, the Ruprecht-Karls-Universität Heidelberg and the FU Berlin. He completed his diploma thesis at the Max Delbrück Center for Molecular Medicine in Berlin-Buch. He completed his doctorate at the Max Planck Institute of Colloids and Interfaces in 2002 at the University of Potsdam in Experimental Physics. After postdoctoral research positions at the Max Planck Institute of Colloids and Interfaces, the University of Genoa, and at the Chair of Biopharmaceutics and Pharmaceutical Technology at Saarland University, he became Junior Professor for Pharmaceutical Nanotechnology (2007). After a research stay at the Chemistry Institute of the Chinese Academy of Sciences in Beijing with Prof. Mingyuan Gao, he took up a professorship for Pharmaceutical Technology and Biopharmacy in Marburg (2013). Since 2015, he was appointed the Chair of Biopharmaceutics and Pharmaceutical Technology at Saarland University.
He authored more than 150 original scientific articles, 17 articles in proceedings, 14 book chapters, 5 editorials and holds 9 patents
Prof. Schneider was co-editor-in-chief of Drug Delivery Letters and is involved in scientific advisory boards of Pharmaceutics and the European Journal of Pharmaceutics and Biopharmaceutics and was, among other things, president of the Controlled Release Society Local Chapter Germany.
His research focuses on the production and application of colloidal drug carrier systems and the characterization